Back to IPOs
Sahajanand Medical Technologies Limited
Mainboard IPOUpcoming
Price band₹327 – ₹344per share · face value ₹1
Minimum investment₹14,7921 lot · 43 shares at upper band
IPO dates15 Oct – 19 OctOpens 15 Oct
Minimum bid: 43 shares and in multiples thereof. Price band ₹327 – ₹344 per share. The investment amount below is calculated at the upper price band.
Selling shareholders in the offer for sale, from the offer document
Sahajanand Medical Technologies develops, manufactures, and markets cardiovascular devices globally. The core business is divided into two primary segments: vascular intervention products, such as coronary stents and balloon catheters, and structural heart devices, including transcatheter aortic valves and occluders. The company generates the majority of its revenue from the sale of vascular intervention devices, with the Supraflex Cruz, a biodegradable polymer-based drug-eluting stent, acting as a major contributor to its sales. Products are distributed across India, Europe, and the rest of the world through a combination of direct, hybrid, and distributor-led models, supported by an extensive network of domestic and international distributors. Operations are backed by manufacturing facilities located in Surat, Hyderabad, and Thailand. Additionally, the business relies heavily on dedicated research and development capabilities to continually enhance existing products and introduce new cardiovascular treatments.